For a rare disease such as vulvar cancer, experience matters. At the Susan F. Smith Center for Women's Cancers Gynecologic Oncology Program,
we have a team of experienced gynecologic cancer specialists that works together to provide comprehensive and compassionate care for patients. We are passionately committed to providing every patient
with the best and most personalized treatment options available, taking advantage of the full range of resources and services of a top-ranked cancer hospital and research center.
Exceptional Care for Patients with Vulvar Cancer — You Have...
A team of gynecologic oncology specialists who diagnose and treat dozens of patients with vulvar cancer, and who are setting treatment guidelines for other physicians around the world.
Minimally-invasive surgical techniques, including laser surgery and sentinel lymph node evaluation, that preserve healthy tissue, reduce recovery time, and minimize surgical risk.
Clinical trials for vulvar cancer, which may not be available elsewhere.
Pioneering research, including a recent clinical trial that found that the drug Tarceva temporarily stalled or reversed the growth of squamous cell vulvar cancers in some women with the disease. The trial marked the first time a targeted therapy
has been tested in patients with vulvar cancer.
Our physicians are evaluating novel, targeted therapies and:
Are among few in the nation to offer 3D image-guided brachytherapy.
Were the first to publish excellent clinical outcomes of the use of Intensity Modulated Radiation Therapy (IMRT) with dose constraints to protect surrounding tissue.
We offer specialized care for women with sexual health or fertility concerns,
and access to a wide array of support services and survivorship care.
Appointments and Second Opinions
As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.
We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.